Want to see PYXS full AI Analyst Report?
Pyxis Oncology (PYXS) Income Statement
Pyxis Oncology Income Statement
Last quarter (Q2 2026), Pyxis Oncology's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q2, Pyxis Oncology's net income was $-25.35M. See Pyxis Oncology’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 13.86M | $ 16.15M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 11.47M | $ 15.67M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 95.89M | $ 105.13M | $ 82.20M | $ 123.48M | $ 69.72M | |
| Depreciation and Amortization | $ 4.51M | $ 2.98M | $ 1.93M | $ 709.00K | $ 647.00K |
| $ -73.72M | $ -65.51M | $ -71.86M | $ -120.01M | $ -75.33M | |
| $ -84.42M | $ -89.46M | $ -82.20M | $ -123.48M | $ -69.72M | |
| $ 6.18M | $ 9.96M | $ 8.41M | $ 2.76M | $ -6.26M | |
| $ -78.23M | $ -79.50M | $ -73.79M | $ -120.72M | $ -75.97M | |
| $ -79.62M | $ -77.33M | $ -73.79M | $ -120.72M | $ -75.97M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.28 | $ -1.32 | $ -1.85 | $ -3.57 | $ -2.53 |
| Diluted EPS | $ -1.28 | $ -1.32 | $ -1.85 | $ -3.57 | $ -2.53 |
| Weighted Average Shares Outstanding | 62.14M | 58.45M | 39.90M | 33.03M | 32.22M |
| Weighted Average Shares Outstanding (Diluted) | 62.14M | 58.45M | 39.90M | 33.03M | 32.22M |
Currency in USD